ANTISOMA PLC has a total of 41 patent applications. Its first patent ever was published in 2002. It filed its patents most often in United Kingdom, EPO (European Patent Office) and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets pharmaceuticals, biotechnology and organic fine chemistry are PHASEBIO PHARMACEUTICALS INC, BILLION KING INTERNATIONAL LTD and INCANTHERA LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | United Kingdom | 7 | |
#2 | EPO (European Patent Office) | 5 | |
#3 | WIPO (World Intellectual Property Organization) | 5 | |
#4 | Brazil | 3 | |
#5 | Canada | 3 | |
#6 | China | 3 | |
#7 | Israel | 3 | |
#8 | Norway | 3 | |
#9 | Ecuador | 2 | |
#10 | Republic of Korea | 2 | |
#11 | Australia | 1 | |
#12 | Morocco | 1 | |
#13 | Mexico | 1 | |
#14 | Poland | 1 | |
#15 | South Africa | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Organic fine chemistry |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Medical preparations | |
#3 | Peptides | |
#4 | Heterocyclic compounds | |
#5 | Microorganisms |
# | Name | Total Patents |
---|---|---|
#1 | Rowlinson-Busza Gail | 23 |
#2 | Kelland Lloyd | 17 |
#3 | Green Colin | 15 |
#4 | Colin Green | 2 |
#5 | Ritchie Christy | 2 |
#6 | Neidle Stephen | 2 |
#7 | Jones David | 2 |
#8 | Doran Benjamin | 2 |
#9 | Stuart John | 2 |
#10 | Glub Dylan | 2 |
Publication | Filing date | Title |
---|---|---|
CA2620436A1 | Combinations comprising dmxaa for the treatment of cancer | |
GB0604114D0 | Combinations for the treatment of cancer | |
GB0519398D0 | Biological materials and uses thereof | |
GB0519397D0 | Biological materials and uses thereof | |
GB0505045D0 | Cancer treatment | |
GB0321746D0 | Modified antibody comprising an amino acid substitution mutation which confers increased stability | |
GB0200657D0 | Cancer treatment |